speb/financial-data huggingface dataset:
DDS balance_sheet (annual, 2026-01-31) — Other Current Borrowings: 96000000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Current Borrowings: 96000000.00
DDS balance_sheet (annual, 2026-01-31) — Other Equity Adjustments: -46674000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: -46674000.00
DDS income_statement (annual, 2026-01-31) — Other Gand A: 1759236000.00
DDS income_statement (quarterly, 2026-01-31) — Other Gand A: 462972000.00
DDS income_statement (annual, 2026-01-31) — Other Income Expense: -424000.00
DDS income_statement (quarterly, 2026-01-31) — Other Income Expense: 9862000.00
DDS cash_flow (annual, 2026-01-31) — Other Non Cash Items: -8782000.00
DDS cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: -1811000.00
DDS balance_sheet (annual, 2026-01-31) — Other Non Current Assets: 93083000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 93083000.00
DDS balance_sheet (annual, 2026-01-31) — Other Non Current Liabilities: 371954000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 371954000.00
DDS income_statement (annual, 2026-01-31) — Other Non Operating Income Expenses: -20797000.00
DDS income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: -5034000.00
DDS balance_sheet (annual, 2026-01-31) — Other Properties: 36177000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Properties: 36177000.00
DDS balance_sheet (annual, 2026-01-31) — Other Short Term Investments: 211497000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 211497000.00
DDS balance_sheet (annual, 2026-01-31) — Payables: 644823000.00
DDS balance_sheet (quarterly, 2026-01-31) — Payables: 644823000.00
DDS balance_sheet (annual, 2026-01-31) — Payables And Accrued Expenses: 796537000.00
DDS balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 796537000.00
DDS income_statement (annual, 2026-01-31) — Pretax Income: 694480000.00
DDS income_statement (quarterly, 2026-01-31) — Pretax Income: 217388000.00
DDS balance_sheet (annual, 2026-01-31) — Properties: 0.00
DDS balance_sheet (quarterly, 2026-01-31) — Properties: 0.00
DDS cash_flow (annual, 2026-01-31) — Purchase Of Business: -34305000.00
DDS cash_flow (quarterly, 2026-01-31) — Purchase Of Business: 0.00
DDS cash_flow (annual, 2026-01-31) — Purchase Of Investment: -534638000.00
DDS cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -138301000.00
DDS cash_flow (annual, 2026-01-31) — Purchase Of PPE: -93382000.00
DDS cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -19544000.00
DDS balance_sheet (annual, 2026-01-31) — Receivables: 39724000.00
DDS balance_sheet (quarterly, 2026-01-31) — Receivables: 39724000.00
DDS income_statement (annual, 2026-01-31) — Reconciled Cost Of Revenue: 3915341000.00
DDS income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 1267832000.00
DDS income_statement (annual, 2026-01-31) — Reconciled Depreciation: 180862000.00
DDS income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 46212000.00
DDS income_statement (annual, 2026-01-31) — Rent And Landing Fees: 19223000.00
DDS income_statement (quarterly, 2026-01-31) — Rent And Landing Fees: 5722000.00
DDS income_statement (annual, 2026-01-31) — Rent Expense Supplemental: 19223000.00
DDS income_statement (quarterly, 2026-01-31) — Rent Expense Supplemental: 5722000.00
DDS cash_flow (annual, 2026-01-31) — Repurchase Of Capital Stock: -107756000.00
DDS cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: 0.00
DDS balance_sheet (annual, 2026-01-31) — Retained Earnings: 6312651000.00
DDS balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 6312651000.00
DDS cash_flow (annual, 2026-01-31) — Sale Of Investment: 657598000.00
DDS cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 113858000.00
DDS income_statement (annual, 2026-01-31) — Selling General And Administration: 1778459000.00
DDS income_statement (quarterly, 2026-01-31) — Selling General And Administration: 468694000.00
DDS balance_sheet (annual, 2026-01-31) — Share Issued: 124069430.00
DDS balance_sheet (quarterly, 2026-01-31) — Share Issued: 124069430.00
DDS income_statement (annual, 2026-01-31) — Special Income Charges: 20373000.00
DDS income_statement (quarterly, 2026-01-31) — Special Income Charges: 14896000.00
DDS balance_sheet (annual, 2026-01-31) — Stockholders Equity: 1778970000.00
DDS balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 1778970000.00
DDS balance_sheet (annual, 2026-01-31) — Tangible Book Value: 1778970000.00
DDS balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 1778970000.00
DDS income_statement (annual, 2026-01-31) — Tax Effect Of Unusual Items: 3646767.00
DDS income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 964113.57
DDS income_statement (annual, 2026-01-31) — Tax Provision: 124700000.00
DDS income_statement (quarterly, 2026-01-31) — Tax Provision: 14070000.00
DDS income_statement (annual, 2026-01-31) — Tax Rate For Calcs: 0.18
DDS income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.06
DDS balance_sheet (annual, 2026-01-31) — Total Assets: 3505023000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Assets: 3505023000.00
DDS balance_sheet (annual, 2026-01-31) — Total Capitalization: 2204644000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 2204644000.00
DDS balance_sheet (annual, 2026-01-31) — Total Debt: 557562000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Debt: 557562000.00
DDS balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 1778970000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 1778970000.00
DDS income_statement (annual, 2026-01-31) — Total Expenses: 5874662000.00
DDS income_statement (quarterly, 2026-01-31) — Total Expenses: 1782738000.00
DDS balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 1726053000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1726053000.00
DDS balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 1118452000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 1118452000.00
DDS balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 823969000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 823969000.00
DDS balance_sheet (annual, 2026-01-31) — Total Tax Payable: 74267000.00
DDS balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 74267000.00
DDS income_statement (annual, 2026-01-31) — Total Unusual Items: 20373000.00
DDS income_statement (quarterly, 2026-01-31) — Total Unusual Items: 14896000.00
DDS income_statement (annual, 2026-01-31) — Total Unusual Items Excluding Goodwill: 20373000.00
DDS income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 14896000.00
DDS balance_sheet (annual, 2026-01-31) — Treasury Shares Number: 108452359.00
DDS balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 108452359.00
DDS balance_sheet (annual, 2026-01-31) — Treasury Stock: 5463597000.00
DDS balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 5463597000.00
DDS balance_sheet (annual, 2026-01-31) — Working Capital: 1484487000.00
DDS balance_sheet (quarterly, 2026-01-31) — Working Capital: 1484487000.00
DDS income_statement (quarterly, 2026-04-30) — +Operating Expense: 491147000.00
DDS income_statement (quarterly, 2026-04-30) — +Total Revenue: 1588621000.00
DDS balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 1081388000.00
DDS balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 47051000.00
DDS balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -2920557000.00
DDS balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 975349000.00
DDS income_statement (quarterly, 2026-04-30) — Basic Average Shares: 15600000.00
DDS income_statement (quarterly, 2026-04-30) — Basic EPS: 16.04
DDS cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 861460000.00
DDS cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -17208000.00
DDS balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 33652000.00
DDS balance_sheet (quarterly, 2026-04-30) — Capital Stock: 1241000.00
DDS balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 1157662000.00
DDS balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 1417405000.00
DDS cash_flow (quarterly, 2026-04-30) — Cash Dividends Paid: -4684000.00
DDS cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -4684000.00
DDS cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -63092000.00
DDS cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 363978000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 313588000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Income Tax Payable: 75947000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Inventory: -305439000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: -4675000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Payable: 389535000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 389535000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Receivables: -7327000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Tax Payable: 75947000.00
DDS cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 72094000.00
DDS cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: -7327000.00
DDS cash_flow (quarterly, 2026-04-30) — Changes In Cash: 296202000.00
DDS balance_sheet (quarterly, 2026-04-30) — Common Stock: 1241000.00
DDS cash_flow (quarterly, 2026-04-30) — Common Stock Dividend Paid: -4684000.00
DDS balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 2025551000.00
DDS cash_flow (quarterly, 2026-04-30) — Common Stock Payments: 0.00
DDS income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 870368000.00
DDS balance_sheet (quarterly, 2026-04-30) — Current Assets: 3047059000.00
DDS balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 9364000.00
DDS balance_sheet (quarterly, 2026-04-30) — Current Debt: 96000000.00
DDS balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 105364000.00
DDS balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 1287318000.00
DDS cash_flow (quarterly, 2026-04-30) — Depreciation: 43680000.00
DDS cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 43680000.00
DDS income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 43278000.00
DDS cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 43680000.00
DDS income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 43278000.00
DDS income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 15600000.00
DDS income_statement (quarterly, 2026-04-30) — Diluted EPS: 16.04
DDS income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — EBIT: 227106000.00
DDS income_statement (quarterly, 2026-04-30) — EBITDA: 270786000.00
DDS income_statement (quarterly, 2026-04-30) — Earnings From Equity Interest Net Of Tax: 298000.00
DDS cash_flow (quarterly, 2026-04-30) — End Cash Position: 1157662000.00
DDS cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -4684000.00
DDS balance_sheet (quarterly, 2026-04-30) — Finished Goods: 1506537000.00
DDS cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 346770000.00
DDS income_statement (quarterly, 2026-04-30) — Gain On Sale Of Ppe: 152000.00
DDS balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -45961000.00
DDS income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 447869000.00
DDS balance_sheet (quarterly, 2026-04-30) — Gross PPE: 3839203000.00
DDS income_statement (quarterly, 2026-04-30) — Gross Profit: 718253000.00
DDS balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 100566000.00
DDS income_statement (quarterly, 2026-04-30) — Interest Income: 699000.00
DDS income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 699000.00
DDS balance_sheet (quarterly, 2026-04-30) — Inventory: 1506537000.00
DDS balance_sheet (quarterly, 2026-04-30) — Invested Capital: 2547252000.00
DDS cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -63092000.00
DDS balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 24288000.00
DDS balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 425701000.00
DDS balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 449989000.00
DDS cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 0.00
DDS income_statement (quarterly, 2026-04-30) — Net Income: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 250553000.00
DDS cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 250553000.00
DDS income_statement (quarterly, 2026-04-30) — Net Interest Income: 699000.00
DDS cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: -46049000.00
DDS income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 699000.00
DDS cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 165000.00
DDS balance_sheet (quarterly, 2026-04-30) — Net PPE: 918646000.00
DDS cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -17208000.00
DDS balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 2025551000.00
DDS balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Assets: 78647000.00
DDS balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Assets: 78647000.00
DDS income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 166553000.00
DDS income_statement (quarterly, 2026-04-30) — Normalized Income: 170791416.64
DDS cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 363978000.00
DDS cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -152000.00
DDS income_statement (quarterly, 2026-04-30) — Operating Income: 227106000.00
DDS income_statement (quarterly, 2026-04-30) — Operating Revenue: 1588621000.00
DDS balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 15617071.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 76066000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Current Borrowings: 96000000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -45961000.00
DDS income_statement (quarterly, 2026-04-30) — Other Gand A: 443980000.00
DDS income_statement (quarterly, 2026-04-30) — Other Income Expense: 99230000.00
DDS cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: -2197000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 93401000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 374895000.00
DDS income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: -5003000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Properties: 3839203000.00
DDS balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 259743000.00
DDS income_statement (quarterly, 2026-04-30) — Other Special Charges: -104081000.00
DDS balance_sheet (quarterly, 2026-04-30) — Payables: 1181954000.00
DDS balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 1181954000.00
DDS income_statement (quarterly, 2026-04-30) — Pretax Income: 327035000.00
DDS cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -258543000.00
DDS cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -17208000.00
DDS balance_sheet (quarterly, 2026-04-30) — Receivables: 47051000.00
DDS income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 869966000.00
DDS income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 43680000.00
DDS income_statement (quarterly, 2026-04-30) — Rent And Landing Fees: 3889000.00
DDS income_statement (quarterly, 2026-04-30) — Rent Expense Supplemental: 3889000.00
DDS cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: 0.00
DDS balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 6558519000.00
DDS cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 212494000.00
DDS income_statement (quarterly, 2026-04-30) — Selling General And Administration: 447869000.00
DDS balance_sheet (quarterly, 2026-04-30) — Share Issued: 15617071.00
DDS income_statement (quarterly, 2026-04-30) — Special Income Charges: 104233000.00
DDS balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 2025551000.00
DDS balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 2025551000.00
DDS income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 24471416.64
DDS income_statement (quarterly, 2026-04-30) — Tax Provision: 76780000.00
DDS income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.23
DDS balance_sheet (quarterly, 2026-04-30) — Total Assets: 4137753000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 2451252000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Debt: 555353000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 2025551000.00
DDS income_statement (quarterly, 2026-04-30) — Total Expenses: 1361515000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 2112202000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 1090694000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 824884000.00
DDS balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 100566000.00
DDS income_statement (quarterly, 2026-04-30) — Total Unusual Items: 104233000.00
DDS income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 104233000.00
DDS balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 5463597000.00
DDS balance_sheet (quarterly, 2026-04-30) — Working Capital: 1759741000.00
DDT.AX income_statement (annual, 2021-06-30) — +Operating Expense: 1520204.00
DDT.AX income_statement (annual, 2021-06-30) — +Total Revenue: 2466542.00
DDT.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 183275.00
DDT.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 940492.00
DDT.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -2068006.00
DDT.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 1249508652.00
DDT.AX income_statement (annual, 2021-06-30) — Basic EPS: 0.00
DDT.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 1005324.00
DDT.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -14729.00
DDT.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 41596795.00
DDT.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 2328358.00
DDT.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 2328358.00
DDT.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 2328358.00
DDT.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -14162.00
DDT.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: 1354221.00
DDT.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 1340059.00
DDT.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -3189350.00
DDT.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 4571493.00
DDT.AX balance_sheet (annual, 2021-06-30) — Common Stock: 41596795.00
DDT.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 3173457.00
DDT.AX income_statement (annual, 2021-06-30) — Cost Of Revenue: 1412128.00
DDT.AX balance_sheet (annual, 2021-06-30) — Current Assets: 3611083.00
DDT.AX balance_sheet (annual, 2021-06-30) — Current Deferred Liabilities: 8895.00
DDT.AX balance_sheet (annual, 2021-06-30) — Current Deferred Revenue: 8895.00
DDT.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 712129.00
DDT.AX balance_sheet (annual, 2021-06-30) — Current Provisions: 7105.00
DDT.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 231829.00
DDT.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 231829.00
DDT.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 231829.00
DDT.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 1249508652.00
DDT.AX income_statement (annual, 2021-06-30) — Diluted EPS: 0.00
DDT.AX income_statement (annual, 2021-06-30) — EBIT: 1262904.00
DDT.AX income_statement (annual, 2021-06-30) — EBITDA: 1494733.00
DDT.AX cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: -17025.00
DDT.AX balance_sheet (annual, 2021-06-30) — Employee Benefits: 16240.00
DDT.AX cash_flow (annual, 2021-06-30) — End Cash Position: 2328358.00
DDT.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: 1339492.00
DDT.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: -2017427.00
DDT.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 1316829.00
DDT.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 2456332.00
DDT.AX income_statement (annual, 2021-06-30) — Gross Profit: 1054414.00
DDT.AX cash_flow (annual, 2021-06-30) — Income Tax Paid Supplemental Data: 8222.00
DDT.AX income_statement (annual, 2021-06-30) — Interest Expense: 19700.00
DDT.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 19700.00
DDT.AX income_statement (annual, 2021-06-30) — Interest Income: 567.00
DDT.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 567.00
DDT.AX cash_flow (annual, 2021-06-30) — Interest Paid Direct: -19700.00
DDT.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 19700.00
DDT.AX cash_flow (annual, 2021-06-30) — Interest Received Cfi: 567.00
DDT.AX balance_sheet (annual, 2021-06-30) — Inventory: 208259.00
DDT.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 3173457.00
DDT.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -14162.00
DDT.AX balance_sheet (annual, 2021-06-30) — Investments And Advances: 2948.00
DDT.AX balance_sheet (annual, 2021-06-30) — Leases: 452312.00
DDT.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 1799900.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Net Interest Income: -19133.00
DDT.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -19133.00
DDT.AX balance_sheet (annual, 2021-06-30) — Net PPE: 388326.00
DDT.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -14729.00
DDT.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 3173457.00
DDT.AX balance_sheet (annual, 2021-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 16240.00
DDT.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: 1494733.00
DDT.AX income_statement (annual, 2021-06-30) — Normalized Income: 1234982.00
DDT.AX income_statement (annual, 2021-06-30) — Operating Income: -465790.00
DDT.AX income_statement (annual, 2021-06-30) — Operating Revenue: 2466542.00
DDT.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 1241869466.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Current Assets: 104067.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 183987.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: -2017427.00
DDT.AX income_statement (annual, 2021-06-30) — Other Gand A: 488161.00
DDT.AX income_statement (annual, 2021-06-30) — Other Income Expense: 1728127.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Investments: 2948.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Non Current Liabilities: 100531.00
DDT.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 1728127.00
DDT.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 1471.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Payable: 225935.00
DDT.AX balance_sheet (annual, 2021-06-30) — Other Properties: 204120.00
DDT.AX balance_sheet (annual, 2021-06-30) — Payables: 409210.00
DDT.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 409210.00
DDT.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -3189350.00
DDT.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 102932.00
DDT.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 206808.00
DDT.AX income_statement (annual, 2021-06-30) — Pretax Income: 1243204.00
DDT.AX income_statement (annual, 2021-06-30) — Provision For Doubtful Accounts: -67131.00
DDT.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -14729.00
DDT.AX balance_sheet (annual, 2021-06-30) — Raw Materials: 208259.00
DDT.AX cash_flow (annual, 2021-06-30) — Receiptsfrom Customers: 4236106.00
DDT.AX cash_flow (annual, 2021-06-30) — Receiptsfrom Government Grants: 335387.00
DDT.AX balance_sheet (annual, 2021-06-30) — Receivables: 763591.00
DDT.AX balance_sheet (annual, 2021-06-30) — Receivables Adjustments Allowances: -176901.00
DDT.AX income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 1412128.00
DDT.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 231829.00
DDT.AX income_statement (annual, 2021-06-30) — Rent And Landing Fees: 78237.00
DDT.AX income_statement (annual, 2021-06-30) — Research And Development: 9238.00
DDT.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -36405911.00
DDT.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 750431.00
DDT.AX income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 27968.00
DDT.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 1344797.00
DDT.AX balance_sheet (annual, 2021-06-30) — Share Issued: 1241869466.00
DDT.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 3173457.00
DDT.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 3173457.00
DDT.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
DDT.AX income_statement (annual, 2021-06-30) — Tax Provision: 8222.00
DDT.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.01
DDT.AX cash_flow (annual, 2021-06-30) — Taxes Refund Paid Direct: -8222.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Assets: 4002357.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 3173457.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 3173457.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 828900.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 391274.00
DDT.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 116771.00
DDT.AX balance_sheet (annual, 2021-06-30) — Working Capital: 2898954.00
DDT.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1705260.00
DDT.AX income_statement (annual, 2022-06-30) — +Total Revenue: 2160992.00
DDT.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 256266.00
DDT.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 544531.00
DDT.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -2261205.00
DDT.AX balance_sheet (annual, 2022-06-30) — Assets Held For Sale Current: -1.00
DDT.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 1243562617.00
DDT.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.01
DDT.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 2328358.00
DDT.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -242209.00
DDT.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 41612795.00
DDT.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 3179549.00
DDT.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 3179549.00
DDT.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 3179549.00
DDT.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -241680.00
DDT.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: 1106549.00
DDT.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 864869.00
DDT.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -3381215.00
DDT.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 4511613.00
DDT.AX balance_sheet (annual, 2022-06-30) — Common Stock: 41612795.00
DDT.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 9679231.00
DDT.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 1203607.00
DDT.AX balance_sheet (annual, 2022-06-30) — Current Assets: 4205715.00
DDT.AX balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 16837.00
DDT.AX balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 16837.00
DDT.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 638823.00
DDT.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 7105.00
DDT.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 202246.00
DDT.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 202246.00
DDT.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 202246.00
DDT.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 1243562617.00
DDT.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.01
DDT.AX income_statement (annual, 2022-06-30) — EBIT: 843539.00
DDT.AX income_statement (annual, 2022-06-30) — EBITDA: 1045785.00
DDT.AX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: -13678.00
DDT.AX balance_sheet (annual, 2022-06-30) — Employee Benefits: 5278.00
DDT.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3179549.00
DDT.AX balance_sheet (annual, 2022-06-30) — Finished Goods: 191235.00
DDT.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: -8270.00
DDT.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: 864340.00
DDT.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 379328.00
DDT.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1399383.00
DDT.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 2687748.00
DDT.AX income_statement (annual, 2022-06-30) — Gross Profit: 957385.00
DDT.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 9473.00
DDT.AX income_statement (annual, 2022-06-30) — Interest Expense: 14376.00
DDT.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 14376.00
DDT.AX income_statement (annual, 2022-06-30) — Interest Income: 529.00
DDT.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 529.00
DDT.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -14376.00
DDT.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 14376.00
DDT.AX cash_flow (annual, 2022-06-30) — Interest Received Cfi: 529.00
DDT.AX balance_sheet (annual, 2022-06-30) — Inventory: 392227.00
DDT.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 9679231.00
DDT.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -241680.00
DDT.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 2948.00
DDT.AX balance_sheet (annual, 2022-06-30) — Leases: 448035.00
DDT.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 2036731.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Net Interest Income: -13847.00
DDT.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -13847.00
DDT.AX balance_sheet (annual, 2022-06-30) — Net PPE: 426543.00
DDT.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -242209.00
DDT.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 9679231.00
DDT.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Assets: 5701507.00
DDT.AX balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Assets: 5701507.00
DDT.AX balance_sheet (annual, 2022-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 5278.00
DDT.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 1045785.00
DDT.AX income_statement (annual, 2022-06-30) — Normalized Income: 6521197.00
DDT.AX income_statement (annual, 2022-06-30) — Operating Income: -747875.00
DDT.AX income_statement (annual, 2022-06-30) — Operating Revenue: 2160992.00
DDT.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 1243869466.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 146521.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 106364.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 387598.00
DDT.AX income_statement (annual, 2022-06-30) — Other Gand A: 511037.00
DDT.AX income_statement (annual, 2022-06-30) — Other Income Expense: 1590885.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Inventories: 1335.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Investments: 2948.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 13381.00
DDT.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 1590885.00
DDT.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 5638.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Payable: 171888.00
DDT.AX balance_sheet (annual, 2022-06-30) — Other Properties: 202982.00
DDT.AX balance_sheet (annual, 2022-06-30) — Payables: 428154.00
DDT.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 428154.00
DDT.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -3381215.00
DDT.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 80363.00
DDT.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 113695.00
DDT.AX income_statement (annual, 2022-06-30) — Pretax Income: 829163.00
DDT.AX income_statement (annual, 2022-06-30) — Provision For Doubtful Accounts: -233.00
DDT.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -242209.00
DDT.AX balance_sheet (annual, 2022-06-30) — Raw Materials: 199657.00
DDT.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 4395672.00
DDT.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Government Grants: 115941.00
DDT.AX balance_sheet (annual, 2022-06-30) — Receivables: 373724.00
DDT.AX balance_sheet (annual, 2022-06-30) — Receivables Adjustments Allowances: -170807.00
DDT.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 1203607.00
DDT.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 202246.00
DDT.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 69010.00
DDT.AX income_statement (annual, 2022-06-30) — Research And Development: 15906.00
DDT.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -32312892.00
DDT.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 819336.00
DDT.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 82320.00
DDT.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1481703.00
DDT.AX balance_sheet (annual, 2022-06-30) — Share Issued: 1243869466.00
DDT.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 9679231.00
DDT.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 9679231.00
DDT.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
DDT.AX income_statement (annual, 2022-06-30) — Tax Provision: -5692034.00
DDT.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.30
DDT.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: -9473.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Assets: 10336713.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 9679231.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 9679231.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 657482.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 6130998.00
DDT.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 18659.00
DDT.AX balance_sheet (annual, 2022-06-30) — Working Capital: 3566892.00
DDT.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1829748.00
DDT.AX income_statement (annual, 2023-06-30) — +Total Revenue: 2364892.00
DDT.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 69188.00
DDT.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 569806.00
DDT.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -2048236.00
DDT.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 1229800966.00
DDT.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.00
DDT.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3179549.00
DDT.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -47185.00
DDT.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 41415295.00
DDT.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 2117501.00
DDT.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 2867501.00
DDT.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 2117501.00
DDT.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -197500.00
DDT.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -763992.00
DDT.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -97372.00
DDT.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -1058864.00
DDT.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -2924366.00
DDT.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2854690.00
DDT.AX balance_sheet (annual, 2023-06-30) — Common Stock: 41415295.00
DDT.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 9269300.00
DDT.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -197500.00
DDT.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 975138.00
DDT.AX balance_sheet (annual, 2023-06-30) — Current Assets: 3889720.00
DDT.AX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 16837.00
DDT.AX balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 16837.00
DDT.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 625876.00
DDT.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 7105.00
DDT.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 226704.00
DDT.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 226704.00
DDT.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 226704.00
DDT.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 1229800966.00
DDT.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.00
DDT.AX income_statement (annual, 2023-06-30) — EBIT: 27719.00
DDT.AX income_statement (annual, 2023-06-30) — EBITDA: 254423.00
DDT.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -3184.00
DDT.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 6595.00
DDT.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2117501.00
DDT.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: -197500.00
DDT.AX balance_sheet (annual, 2023-06-30) — Finished Goods: 199049.00
DDT.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: -8431.00
DDT.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -144557.00
DDT.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 282267.00
DDT.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1557370.00
DDT.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 2873615.00
DDT.AX income_statement (annual, 2023-06-30) — Gross Profit: 1389754.00
DDT.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 11624.00
DDT.AX income_statement (annual, 2023-06-30) — Interest Expense: 16072.00
DDT.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 16072.00
DDT.AX income_statement (annual, 2023-06-30) — Interest Income: 41010.00
DDT.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 41010.00
DDT.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -16072.00
DDT.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 16072.00
DDT.AX cash_flow (annual, 2023-06-30) — Interest Received Cfi: 33193.00
DDT.AX balance_sheet (annual, 2023-06-30) — Inventory: 452460.00
DDT.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 9269300.00
DDT.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -763992.00
DDT.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 2948.00
DDT.AX balance_sheet (annual, 2023-06-30) — Leases: 587034.00
DDT.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 2081369.00
DDT.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: -197500.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Net Interest Income: 24938.00
DDT.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -750000.00
DDT.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 24938.00
DDT.AX balance_sheet (annual, 2023-06-30) — Net PPE: 825379.00
DDT.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -47185.00
DDT.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 9269300.00
DDT.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Assets: 5489215.00
DDT.AX balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 5489215.00
DDT.AX balance_sheet (annual, 2023-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 6595.00
DDT.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: 254423.00
DDT.AX income_statement (annual, 2023-06-30) — Normalized Income: -115370.00
DDT.AX income_statement (annual, 2023-06-30) — Operating Income: -439994.00
DDT.AX income_statement (annual, 2023-06-30) — Operating Revenue: 2364892.00
DDT.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 1210952783.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 46350.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 207448.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 290698.00
DDT.AX income_statement (annual, 2023-06-30) — Other Gand A: 570896.00
DDT.AX income_statement (annual, 2023-06-30) — Other Income Expense: 426703.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Investments: 2948.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 1.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Non Current Liabilities: 305492.00
DDT.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 426703.00
DDT.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 6672.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Payable: 226328.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Properties: 205212.00
DDT.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 750000.00
DDT.AX balance_sheet (annual, 2023-06-30) — Payables: 295516.00
DDT.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 295516.00
DDT.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -2924366.00
DDT.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 98970.00
DDT.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 136267.00
DDT.AX income_statement (annual, 2023-06-30) — Pretax Income: 11647.00
DDT.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -47185.00
DDT.AX balance_sheet (annual, 2023-06-30) — Raw Materials: 253411.00
DDT.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 2734814.00
DDT.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Government Grants: 119876.00
DDT.AX balance_sheet (annual, 2023-06-30) — Receivables: 387142.00
DDT.AX balance_sheet (annual, 2023-06-30) — Receivables Adjustments Allowances: -182664.00
DDT.AX income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 975138.00
DDT.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 226704.00
DDT.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 64252.00
DDT.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -197500.00
DDT.AX income_statement (annual, 2023-06-30) — Research And Development: 1750.00
DDT.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -32428262.00
DDT.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 922222.00
DDT.AX cash_flow (annual, 2023-06-30) — Sale Of Investment: -750000.00
DDT.AX income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 37252.00
DDT.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1594622.00
DDT.AX balance_sheet (annual, 2023-06-30) — Share Issued: 1210952783.00
DDT.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 9269300.00
DDT.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 9269300.00
DDT.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
DDT.AX income_statement (annual, 2023-06-30) — Tax Provision: 127017.00
DDT.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.30
DDT.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: -11624.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Assets: 10207263.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 9269300.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 9269300.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 937963.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 6317543.00
DDT.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 312087.00
DDT.AX balance_sheet (annual, 2023-06-30) — Working Capital: 3263844.00
DDT.AX income_statement (annual, 2024-06-30) — +Operating Expense: 1878295.00
DDT.AX income_statement (annual, 2024-06-30) — +Total Revenue: 2707991.00
DDT.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 240791.00
DDT.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 772326.00
DDT.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -2301584.00